LDB2 and colorectal carcinoma: On the other hand, the model containing GALNT9, UPF3A, WARS, and LDB2 yielded an AUC of 0.864 (95% CI 0.798–0.931), with 62.1% sensitivity and 97.4% specificity for AN, detecting 28/42 AA (66.7%; 78.3% distal and 52.6% proximal), and 13/24 CRC cases (54.2%; 37.5 stage I and 75% stage II).